(SLE)
ROSOPATAMAB TETRAXETAN(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS FOLH1 (FOLATE HYDROLASE, PROSTATE SPECIFIC MEMBRANE ANTIGEN, PSMA)], MONOCLONAL ANTIBODY, TETRAXETAN CONJUGATE; GAMMA1 HEAVY CHAIN (1-445) [VH (MUS MUSCULUS IGHV1-26*01 (78.4%) -(IGHD) -IGHJ2*01 (92.9%)/HOMO SAPIENS IGHV1-69-2*01 (76.3%) - (IGHD) -IGHJ4*01 (92.9%)) [8.8.8] (1-115) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 (CH1 K120 (212) (116-213), HINGE 1-15 (214-228), CH2 (229-338), CH3 D12 (354), L14 (356) (339-443), CHS (444-445)) (116- 445)], (218-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') [V-KAPPA (MUS MUSCULUS IGKV6-23*01 (80.9%) -IGKJ2*03 (72.7%)HOMO SAPIENS IGKV1- 13*02 (78.7%) -IGKJ3*01 (91.7%)) [6.3.9] (1'-107') - HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (224-224":227-227")-BISDISULFIDE; PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA, TETRAXETAN (DOTA) CONJUGATE (ON AN AVERAGE OF 3 TO 5 LYSYL, LINKED TO THE CHELATOR BY THEIR N6)(WHO)
ROSOPATAMABUM TETRAXETANUM(INNM)